Rakesh K. Srivastava

Rakesh K. Srivastava publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Rakesh K. Srivastava sits on this spectrum.

Rakesh K. Srivastava D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Rakesh K. Srivastava sits on this spectrum.

Best Publications

• Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.

  Unknown

  554
  Citations

• Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase.

  Rakesh K. Srivastava;Aparna R. Srivastava;Stanley J. Korsmeyer;Maria Nesterova

  477
  Citations

• Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis

  R K Srivastava;Q S Mi;J M Hardwick;D L Longo

  437
  Citations

• Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential

  Unknown

  434
  Citations

• Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer

  Unknown

  395
  Citations

• Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition.

  Unknown

  380
  Citations

• TRAIL/Apo-2L : mechanisms and clinical applications in cancer

  Unknown

  353
  Citations

• Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells.

  Unknown

  311
  Citations

• Enhancement of therapeutic potential of TRAIL by cancer chemotherapy and irradiation: mechanisms and clinical implications

  Unknown

  298
  Citations

• Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer

  Unknown

  288
  Citations

• Involvement of Proapoptotic Molecules Bax and Bak in Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-induced Mitochondrial Disruption and Apoptosis: Differential Regulation of Cytochrome c and Smac/DIABLO Release

  Karthikeyan Kandasamy;Srinivasa M Srinivasula;Emad S Alnemri;Craig B Thompson

  283
  Citations

• Differential Roles of RelA (p65) and c-Rel Subunits of Nuclear Factor κB in Tumor Necrosis Factor-related Apoptosis-inducing Ligand Signaling

  Unknown

  280
  Citations

• The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition

  Unknown

  268
  Citations

• Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway.

  Unknown

  233
  Citations

• Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells

  Unknown

  229
  Citations

• Green tea polyphenols: biology and therapeutic implications in cancer.

  Unknown

  226
  Citations

• Bcl-2 and Bcl-X(L) block thapsigargin-induced nitric oxide generation, c-Jun NH(2)-terminal kinase activity, and apoptosis.

  Rakesh K. Srivastava;Steven J. Sollott;Leila Khan;Richard Hansford

  215
  Citations

• Resveratrol Induces Growth Arrest and Apoptosis through Activation of FOXO Transcription Factors in Prostate Cancer Cells

  Unknown

  214
  Citations

• Histone deacetylase inhibitors: mechanisms and clinical significance in cancer: HDAC inhibitor-induced apoptosis.

  Unknown

  209
  Citations

• Interactive effects of HDAC inhibitors and TRAIL on apoptosis are associated with changes in mitochondrial functions and expressions of cell cycle regulatory genes in multiple myeloma.

  Tamer E. Fandy;Sharmila Shankar;Douglas D. Ross;Edward Sausville

  207
  Citations